This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
One of the sad aspects of the current controversy concerning drugs, their indications and contraindications, their usefulness and even their need, the matter of great expense to the patient, is that accurate, unbiased information is available to every physician in the United States. New and Nonofficial Drugs is a small handy volume which brings up to date every year the newest and best in drug therapy. Here the chemist, the researcher both pure and clinical types, the pharmaceutical manufacturer, and the medical journalist meet on neutral ground, under the auspices of the American Medical Association Council on Drugs.
The evaluation, analysis, and condensing of thousands of references into a small reference work is a herculean, never-ending task. Through the courtesy of Dr. John R. Lewis, Acting Secretary of the Council, I was privileged to observe all the steps involved from the submission of a product through the collection of evidence
Gorrell RL. New and Nonofficial Drugs 1964.. Arch Intern Med. 1964;114(4):572–573. doi:10.1001/archinte.1964.03860100154038
Customize your JAMA Network experience by selecting one or more topics from the list below.